Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2/3 2Phase 2 1

Status

Unknown 15Completed 9Not yet recruiting 5Recruiting 3Active not recruiting 2Terminated 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Head & Neck 5

Conditions

Colorectal Neoplasms 11Pancreatic Neoplasms 6Nasopharyngeal Carcinoma 5Cholangiocarcinoma 4Biliary Tract Neoplasms 4Rectal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Colonic Neoplasms 3Cirrhosis, Familial, with Pulmonary Hypertension 3Stomach Neoplasms 2Neoplasm Metastasis 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Neuroendocrine 2Urinary Bladder Neoplasms 1Rare Tumour 1Pathologic Complete Response 1Pancreatic Cancer Resectable 1PDAC - Pancreatic Ductal Adenocarcinoma 1Neoplasms, Second Primary 1Neoplasms 1Neoplasm, Residual 1Neoadjuvant Chemotherapy 1Muscle Neoplasms 1Locally Advanced Low Rectal Adenocarcinoma 1Liver Neoplasms 1Liver Metastases of Colorectal Cancer 1Keratosis, Actinic 1HER2-positive Gastric Cancer 1Gastrointestinal Neoplasms 1

Interventions

Cisplatin 11toripalimab 8Capecitabine 8Gemcitabine 6Fluorouracil 5tislelizumab 4Radiotherapy, Intensity-Modulated 4Radiotherapy 3sintilimab 2anlotinib 2Taxes 2Radiation 2Drug Therapy 2spartalizumab 1pembrolizumab 1palbociclib 1nedaplatin 1lobaplatin 1camrelizumab 1Valganciclovir 1Therapeutics 1Taurine 1Sodium Fluoride 1Single Person 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Leyk 1LY-2157299 1Induction Chemotherapy 1Docosahexaenoic Acids 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × Nasopharyngeal Carcinoma × Fluorouracil × Clear all
NCT06781112 2025-01-17

A Phase II Study of TPF With PD-1 Inhibitor Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma

Chengdu University of Traditional Chinese Medicine

Phase 2 Not yet recruiting
35 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT05780294 2023-03-22

A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC

Sun Yat-sen University

Phase 3 Not yet recruiting
132 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT05433597 2022-06-27

A Two-blinded, Multicentre, Phase II/III RCT of Concurrent Chemo-radiotherapy Combined or Not Combined With TNF as the Therapy for LA-NPC

Sun Yat-sen University

Phase 2/3 Not yet recruiting
172 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT04890522 2021-05-18

An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC

Sun Yat-sen University

Phase 2/3 Not yet recruiting
622 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Neoplasm Metastasis

NCT03503136 2018-05-11

NX-NPC

Sun Yat-sen University

Phase 3 Not yet recruiting
632 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡